Get Accrufer Updates and More

This website is intended for US healthcare professionals only.

Sign Up to Receive Updates and Additional Information About ACCRUFeR^® (ferric maltol).

Required

I am a

Patient

Healthcare Provider

Title

First Name

Last Name

HCP Type

Zip

* I certify that I am at least 18 years of age, and want to receive information from Shield Therapeutics, and third parties working on behalf of Shield Therapeutics. I agree that Shield Therapeutics may use the information I provide to send me health related materials, as well as information on Shield Therapeutics products and services, including marketing programs. Shield Therapeutics may also use my information for market research, or to evaluate and improve the company’s programs and services.

INDICATIONS & USAGE

ACCRUFeR^® (ferric maltol) is indicated for the treatment of iron deficiency in adults.

IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS

ACCRUFeR is contraindicated in patients with a history of:

Hypersensitivity to ACCRUFeR or any of its inactive components
Hemochromatosis and other iron overload syndromes
Receiving repeated blood transfusions as this may result in iron overload

Sign Up to Receive Updates
and Stay Informed

Sign Up to Receive Updates and Additional Information About ACCRUFeR^® (ferric maltol).

INDICATIONS & USAGE

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

INDICATIONS & USAGE

IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS

Sign Up to Receive Updates and Stay Informed

Sign Up to Receive Updates and Additional Information About ACCRUFeR® (ferric maltol).

Sign Up to Receive Updates
and Stay Informed

Sign Up to Receive Updates and Additional Information About ACCRUFeR^® (ferric maltol).